Guizhou Sanli Pharmaceutical Co Ltd (603439) — Cash Flow Quality Index
Guizhou Sanli Pharmaceutical Co Ltd (603439) has a Cash Flow Quality Index of 0.78x as of June 2025. Operating cash flow of CN¥32.03 Million is below net income of CN¥41.11 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Guizhou Sanli Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guizhou Sanli Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Guizhou Sanli Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603439 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Guizhou Sanli Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Guizhou Sanli Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | CN¥107.07 Million | CN¥279.84 Million | ▼ -59.5% |
| 2023 | 0.95x | CN¥276.70 Million | CN¥292.70 Million | ▼ -38.1% |
| 2022 | 1.53x | CN¥293.29 Million | CN¥191.94 Million | ▲ +46.5% |
| 2021 | 1.04x | CN¥155.04 Million | CN¥148.60 Million | ▲ +55.0% |
| 2020 | 0.67x | CN¥63.25 Million | CN¥93.95 Million | ▼ -22.9% |
| 2019 | 0.87x | CN¥116.24 Million | CN¥133.07 Million | ▲ +28.1% |
| 2018 | 0.68x | CN¥75.35 Million | CN¥110.48 Million | ▲ +4.0% |
| 2017 | 0.66x | CN¥57.47 Million | CN¥87.63 Million | ▲ +39.9% |
| 2016 | 0.47x | CN¥35.10 Million | CN¥74.88 Million | ▼ -25.9% |
| 2015 | 0.63x | CN¥33.28 Million | CN¥52.61 Million | ▲ +3154.9% |
| 2014 | 0.02x | CN¥563.46K | CN¥28.99 Million | ▼ -98.7% |
| 2013 | 1.55x | CN¥30.09 Million | CN¥19.37 Million | — |